HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment outcomes of intensity-modulated radiotherapy versus 3D conformal radiotherapy for patients with maxillary sinus cancer in the postoperative setting.

AbstractBACKGROUND:
In this study, we compared the treatment outcomes of postoperative 3D conformal radiotherapy (RT) and intensity-modulated radiotherapy (IMRT) for patients with maxillary sinus carcinoma.
METHODS:
Fifty-four patients underwent surgery and postoperative RT, of whom 27 (50%) had squamous cell carcinoma and 14 (26%) had adenoid cystic carcinoma. Nineteen patients (35%) were treated with IMRT and 35 patients (65%) received 3D conformal RT. The median radiation dose for 3D conformal RT and IMRT were 62.1 and 63 Gy, respectively.
RESULTS:
IMRT produced significantly superior radiation dose distribution to planning target volumes (PTVs) than 3D conformal RT. Over a median follow-up of 60 months, IMRT provided better 3-year locoregional recurrence-free survival (89.2% vs 59.5%; p = .035) and distant metastasis-free survival (94.7% vs 55.3%; p = .042) rates than 3D conformal RT.
CONCLUSION:
Postoperative IMRT for patients with maxillary sinus carcinoma resulted in excellent disease control, and should be considered as the first treatment option in these cases. © 2015 Wiley Periodicals, Inc. Head Neck 38: E207-E213, 2016.
AuthorsYang-Gun Suh, Chang Geol Lee, Hyunju Kim, Eun Chang Choi, Se Hun Kim, Chang-Hoon Kim, Ki Chang Keum
JournalHead & neck (Head Neck) Vol. 38 Suppl 1 Pg. E207-13 (04 2016) ISSN: 1097-0347 [Electronic] United States
PMID25538027 (Publication Type: Comparative Study, Journal Article)
Copyright© 2015 Wiley Periodicals, Inc.
Topics
  • Adult
  • Aged
  • Carcinoma, Adenoid Cystic (radiotherapy)
  • Carcinoma, Squamous Cell (radiotherapy)
  • Female
  • Humans
  • Male
  • Maxillary Sinus Neoplasms (radiotherapy)
  • Middle Aged
  • Radiotherapy Dosage
  • Radiotherapy, Conformal
  • Radiotherapy, Intensity-Modulated
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: